Chronic Hepatitis C Which Patients are "suitable" for a Therapy?

被引：0
作者：
Weickert, U. [1 ]
机构：
[1] Klinikum Stadt Ludwigshafen gGmbH, Med Klin C, Bremserstr 79, D-67063 Ludwigshafen, Germany
来源：
GASTROENTEROLOGE | 2006年 / 1卷 / 02期
关键词：
D O I：
10.1007/s11377-006-0024-y
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：144 / 145
页数：2
相关论文
共 5 条
[1]   Chronic hepatitis C with normal aminotransferase levels [J].
Ahmed, A ;
Keeffe, EB .
GASTROENTEROLOGY, 2004, 126 (05) :1409-1415
[2]   American Gastroenterological Association technical review on the management of hepatitis C [J].
Dienstag, JL ;
McHutchison, JG .
GASTROENTEROLOGY, 2006, 130 (01) :231-264
[3]   Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans [J].
Marschall, HU ;
Wagner, M ;
Zollner, G ;
Fickert, P ;
Diczfalusy, U ;
Gumhold, J ;
Silbert, D ;
Fuchsbichler, A ;
Benthin, L ;
Grundström, R ;
Gustafsson, U ;
Sahlin, S ;
Einarsson, C ;
Trauner, M .
GASTROENTEROLOGY, 2005, 129 (02) :476-485
[4]   Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia [J].
Zeuzem, S ;
Buti, M ;
Ferenci, P ;
Sperl, J ;
Horsmans, Y ;
Cianciara, J ;
Ibranyi, E ;
Weiland, O ;
Noviello, S ;
Brass, C ;
Albrecht, J .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :97-103
[5]   Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels [J].
Zeuzem, S ;
Diago, M ;
Gane, E ;
Reddy, KR ;
Pockros, P ;
Prati, D ;
Shiffman, M ;
Farci, P ;
Gitlin, N ;
O'Brien, CB ;
Lamour, F ;
Lardelli, P .
GASTROENTEROLOGY, 2004, 127 (06) :1724-1732
1